The results showed that GOLT1B was up-regulated in 25 types of tumors, such as breast invasive carcinoma (BRCA), adrenal cortical carcinoma (ACC), cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), clear cell carcinoma of the kidney (KIRC), squamous cell carcinoma of the head and neck (HNSC), liver hepatocellular carcinoma (LIHC), acute myeloid leukemia (LAML). This evidence concerns the gene GOLT1B and invasive breast carcinoma.